DRD2 and depressive symptom measurement: A multi-ancestry GWAS identified 53 novel Depression risk loci, with fine-mapping and multi-omics integration pinpointing 43 high-confidence genes including DRD2 (dopamine receptor D2) and mitochondrial gene NDUFAF3, revealing substantial ancestral heterogeneity in genetic architecture [9].